Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02669888Phase 2Completed
Phase 2, randomised, double-blind trial of lindioil in atopic dermatitis (AD), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Percentage change in Eczema Area Severity Index scores at 6 weeks. Started Oct 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02669888.